Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · July 13, 2023

Determinants of Overall Survival in Metastatic Uveal Melanoma Identified

Female sex, anti-CTLA‐4 therapy, and anti-PD‐1 therapy linked to better overall survival, while worse survival seen with hepatic metastases



Further Reading